Sera Prognostics, Inc. (SERA)
2.04
+0.02
(+0.99%)
USD |
NASDAQ |
Oct 09, 16:00
2.07
+0.03
(+1.47%)
Pre-Market: 20:00
Sera Prognostics Free Cash Flow (Quarterly) : -6.363M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.363M |
| March 31, 2026 | -8.782M |
| December 31, 2025 | -6.45M |
| September 30, 2025 | -6.589M |
| June 30, 2025 | -5.754M |
| March 31, 2025 | -7.556M |
| December 31, 2024 | -6.321M |
| September 30, 2024 | -7.316M |
| June 30, 2024 | -5.935M |
| March 31, 2024 | 4.282M |
| December 31, 2023 | -6.781M |
| September 30, 2023 | -7.62M |
| June 30, 2023 | -7.995M |
| Date | Value |
|---|---|
| March 31, 2023 | -4.92M |
| December 31, 2022 | -7.431M |
| September 30, 2022 | -9.149M |
| June 30, 2022 | -9.257M |
| March 31, 2022 | -9.564M |
| December 31, 2021 | -9.901M |
| September 30, 2021 | -9.725M |
| June 30, 2021 | -6.323M |
| March 31, 2021 | -6.991M |
| December 31, 2020 | -4.229M |
| September 30, 2020 | -4.006M |
| June 30, 2020 | -4.159M |
| March 31, 2020 | -4.623M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -11.50M |
| BioRestorative Therapies, Inc. | -3.808M |
| CareDx, Inc. | 28.75M |
| Natera, Inc. | -8.636M |
| Exagen, Inc. | 3.445M |